Furthermore, transcriptional profiling of Oncopig STS cell lines and tumors indicates Oncopig STS exhibits altered TP53 signaling, Wnt signaling activation, and signs of epigenetic reprogramming, all of which represent transcriptional hallmarks of human STS (Schachtschneider et al., 2017a). The gene discussed is TP53; the disease is telomere syndrome.